Table 2 Activities and research conducted at the clinical research networks
Activities conducted by the networks (% response) Rating scale: 0 = no activities, 5 = major activities | 0 | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|---|
Basic Research | 35 | 29 | 6 | 12 | 3 | 15 |
Translational Research | 12 | 18 | 9 | 9 | 15 | 38 |
Clinical Research | 3 | 3 | 15 | 15 | 18 | 47 |
Diagnosis | 12 | 21 | 6 | 3 | 21 | 38 |
Treatment and Care | 12 | 15 | 18 | 6 | 12 | 38 |
Preventive Medicine | 29 | 27 | 3 | 12 | 9 | 21 |
Training and Fellowships for Health Care Providers and Researchers | 12 | 24 | 12 | 12 | 24 | 18 |
Patients and General Public Education, Information Development and Dissemination | 12 | 12 | 18 | 15 | 15 | 29 |
Organisation of Scientifc Conferences and Workshops | 3 | 10 | 23 | 16 | 23 | 26 |
Research conducted by the networks (% response) Rating scale: 0 = no activities, 5 = major activities | 0 | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|---|
Cellular Models of Diseases | 53 | 15 | 12 | 0 | 0 | 21 |
Creation and Study of Animal Models of Diseases | 47 | 18 | 12 | 3 | 6 | 15 |
Development of Computational Models of Diseases | 47 | 21 | 9 | 6 | 12 | 6 |
Novel Genes discovery | 29 | 9 | 12 | 12 | 9 | 29 |
Clinical Trials | 21 | 18 | 15 | 6 | 12 | 29 |
Cohort Studies | 12 | 9 | 21 | 9 | 6 | 44 |
Natural History Studies | 29 | 3 | 9 | 12 | 9 | 38 |
Clinical Outcome Assessment and Biomarker Validation | 24 | 12 | 9 | 12 | 15 | 29 |
Therapeutics/Drug development | 41 | 21 | 6 | 15 | 15 | 3 |
Post-marketing surveillance | 56 | 15 | 6 | 9 | 6 | 9 |
Health Technology Assessment | 50 | 21 | 9 | 9 | 3 | 9 |
Behavioural studies (psycho-social) | 53 | 6 | 12 | 12 | 12 | 6 |
Rehabilitation studies | 55 | 16 | 16 | 10 | 0 | 3 |